Mitoxantrone-induced extravasation

Oncology Nursing Forum

Volumn 32, Issue 1, 2005, Pages 27-29

  Luke, Enza ^a  

^a Hematology/Oncology Medical Group of Orange   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MITOXANTRONE;

ARTICLE; CASE REPORT; CONTRAST MEDIUM EXTRAVASATION; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NECROSIS; NURSING; PLASTIC SURGERY; RISK FACTOR;

ANTINEOPLASTIC AGENTS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; MALE; MIDDLE AGED; MITOXANTRONE; MULTIPLE SCLEROSIS; NECROSIS; RISK FACTORS; SURGERY, PLASTIC;

EID: 33645225032     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/05.ONF.27-29     Document Type: Note

References (12)

1. Alley, E., Green, R., & Schuchter, L. (2002). Cutaneous toxicities of cancer therapy. Current Opinion in Oncology, 14, 212-216.
2. Brown, K.A., Esper, P., Kelleher, L.O., O'Neil, J.E.B., Polovich, M., & White, J.M. (2001). Chemotherapy and biotherapy: Guidelines and recommendations for practice. Pittsburgh, PA: Oncology Nursing Society.
3. Camp-Sorrell, D. (1998). Developing extravasation protocols and monitoring outcomes. Journal of Intravenous Nursing, 21, 232-239.
4. Dorsett, D.S. (2000). Quality of care. In C.H. Yarbo, M.H. Frogge, M. Goodman, & S.L. Groenwald (Eds.), Cancer nursing: Principles and practice (5th ed., pp. 1581-1608). Sudbury, MA: Jones and Bartlett.
5. Gonsette, R.E. (2003). Mitoxantrone in progressive multiple sclerosis: When and how to treat? Journal of the Neurological Sciences, 206, 203-208.
6. Goodman, M., & Peterson, J. (1997). Tips for administering chemotherapy. In R.A. Gates & R.M. Fink (Eds.), Oncology nursing secrets (pp. 45-55). Philadelphia: Hanley and Belfus.
7. Hadaway, L.C. (2002). I.V. infiltration: Not just a peripheral problem. Nursing, 32(8), 36-42.
8. Harris, P.A., & Moss, A.L. (2002). Management of extravasation injuries. ANZ Journal of Surgery, 72, 684.
9. Hartung, H.P., Gonsette, R., Konig, N., Kwiecinski, H., Guseo, A., Morrisey, S.P., et al. (2002). Mitoxantrone in progressive multiple sclerosis: A placebo-controlled, double-blind, randomised, multicentre trial. Lancet, 360, 2018-2025.
10. Immunex. (2002). Novantrone® [Package insert]. Thousand Oaks, CA: Author.
11. Langstein, H.N., Duman, H., Seelig, D., Butler, C.E., & Evans, G.R. (2002). Retrospective study of the management of chemotherapeutic extravasation injury. Annals of Plastic Surgery, 49, 369-374.
12. Skokal, W.A. (2001). Drug disasters: Extravasation. RN, 64(9), 56-62.